Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Aug 29, 2024

BUY
$7.37 - $10.09 $7,370 - $10,090
1,000 New
1,000 $8,000
Q4 2023

Aug 29, 2024

BUY
$1.37 - $7.24 $1,370 - $7,240
1,000 New
1,000 $7,000
Q4 2023

Feb 28, 2024

BUY
$1.37 - $7.24 $1,370 - $7,240
1,000 New
1,000 $7,000

Others Institutions Holding STTK

About Shattuck Labs, Inc.


  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $46.6M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track University Of Texas Portfolio

Follow University Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of University Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on University Of Texas with notifications on news.